1992
DOI: 10.1111/j.1600-0536.1992.tb00899.x
|View full text |Cite
|
Sign up to set email alerts
|

Contact dermatitis from tioconazole with cross‐sensitivity to other imidazoles

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
13
0

Year Published

1999
1999
2021
2021

Publication Types

Select...
6
3
1

Relationship

0
10

Authors

Journals

citations
Cited by 28 publications
(13 citation statements)
references
References 4 publications
0
13
0
Order By: Relevance
“…In our patient, topical provocation was positive to metronidazole, but despite its pharmacological similarity, tinidazole was negative on topical provocation. Izu et al (4) described cross‐reactivity between metronidazole (a nitroimidazole) and tioconazole (a phenethyl imidazole), in a patient with contact dermatitis due to tioconazole. In our patient, topical provocation with tioconazole was negative.…”
Section: Discussionmentioning
confidence: 99%
“…In our patient, topical provocation was positive to metronidazole, but despite its pharmacological similarity, tinidazole was negative on topical provocation. Izu et al (4) described cross‐reactivity between metronidazole (a nitroimidazole) and tioconazole (a phenethyl imidazole), in a patient with contact dermatitis due to tioconazole. In our patient, topical provocation with tioconazole was negative.…”
Section: Discussionmentioning
confidence: 99%
“…The authors recommended that patients with contact allergy to any imidazole should be patch tested with other imidazoles because of the possibility of cross-reactivity. 150 Mupirocin. Mupirocin is produced by fermentation of the organism Pseudomonas fluorescens and inhibits bacterial protein synthesis by reversibly and specifically binding to bacterial isoleucyl t-RNA synthetase.…”
Section: Macrolidesmentioning
confidence: 99%
“…Publications on allergic contact dermatitis caused by tioconazole became common following its introduction, in the years 1989 to 1996, and many were related to exposure to a medicated nail solution (Table S2). Interestingly, to our knowledge, no cases have been reported since then in the English‐language literature.…”
Section: Discussionmentioning
confidence: 92%